These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34618172)

  • 1. Indications of IMRT, PRT and CIRT for HCC from comparisons of dosimetry and normal tissue complication possibility.
    Sun J; Wang Z; Sheng Y; Ming X; Jiang GL; Wang W
    Strahlenther Onkol; 2022 Apr; 198(4):361-369. PubMed ID: 34618172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric rationale and preliminary experience in proton plus carbon-ion radiotherapy for esophageal carcinoma: a retrospective analysis.
    Ma N; Ming X; Chen J; Wu KL; Lu J; Jiang G; Mao J
    Radiat Oncol; 2023 Dec; 18(1):195. PubMed ID: 38041122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy.
    Toramatsu C; Katoh N; Shimizu S; Nihongi H; Matsuura T; Takao S; Miyamoto N; Suzuki R; Sutherland K; Kinoshita R; Onimaru R; Ishikawa M; Umegaki K; Shirato H
    Radiat Oncol; 2013 Mar; 8():48. PubMed ID: 23497543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic analysis of radiation-induced liver damage following carbon-ion radiotherapy for hepatocellular carcinoma.
    Hayashi K; Suzuki O; Wakisaka Y; Ichise K; Uchida H; Anzai M; Hasegawa A; Seo Y; Shimizu S; Ishii T; Teshima T; Fujimoto J; Ogawa K
    Radiat Oncol; 2024 Apr; 19(1):51. PubMed ID: 38649902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world.
    Zhang W; Hu W; Hu J; Gao J; Yang J; Kong L; Lu JJ
    Cancer Sci; 2020 Dec; 111(12):4465-4479. PubMed ID: 32936975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
    Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
    Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.
    Kuo YC; Chiu YM; Shih WP; Yu HW; Chen CW; Wong PF; Lin WC; Hwang JJ
    Radiat Oncol; 2011 Jun; 6():76. PubMed ID: 21693003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma.
    Chen D; Wang R; Meng X; Liu T; Yan H; Feng R; Liu S; Jiang S; Xu X; Zhu K; Dou X
    Radiat Oncol; 2014 Feb; 9():48. PubMed ID: 24502643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Tsai SY; Cheng SH; Jian JJ; Huang AT
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):229-34. PubMed ID: 12694843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
    Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
    Haefner MF; Verma V; Bougatf N; Mielke T; Tonndorf-Martini E; König L; Rwigema JM; Simone CB; Uhlmann L; Eichhorn F; Winter H; Grosch H; Haberer T; Herfarth K; Debus J; Rieken S
    Acta Oncol; 2018 Dec; 57(12):1713-1720. PubMed ID: 30264630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
    Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
    Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon-ion radiotherapy boost with standard dose proton radiation for incomplete-resected high-grade glioma: a phase 1 study.
    Qiu X; Gao J; Yang J; Hu J; Hu W; Huang Q; Kong L; Lu JJ
    Ann Transl Med; 2022 Nov; 10(22):1193. PubMed ID: 36544659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up modulation of dose-averaged linear energy transfer by simultaneous integrated boost in carbon-ion radiotherapy for pancreatic carcinoma.
    Wang W; Sun J; Zhao J; Cheng J; Jiang GL; Wang Z
    J Appl Clin Med Phys; 2024 Jun; 25(6):e14279. PubMed ID: 38259194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment planning study to determine potential benefit of intensity-modulated radiotherapy versus conformal radiotherapy for unresectable hepatic malignancies.
    Eccles CL; Bissonnette JP; Craig T; Taremi M; Wu X; Dawson LA
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):582-8. PubMed ID: 18793961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Vaginal Immobilization Device: A Treatment-planning Study of Carbon-ion Radiotherapy and Intensity-modulated Radiation Therapy for Uterine Cervical Cancer.
    Kubota Y; Ohno T; Kawashima M; Murata K; Okonogi N; Noda SE; Tsuda K; Sakai M; Tashiro M; Nakano T
    Anticancer Res; 2019 Apr; 39(4):1915-1921. PubMed ID: 30952733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma.
    Abe T; Saitoh J; Kobayashi D; Shibuya K; Koyama Y; Shimada H; Shirai K; Ohno T; Nakano T
    Radiat Oncol; 2015 Sep; 10():187. PubMed ID: 26377092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed-beam approach for high-risk prostate cancer: Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300).
    Gugliandolo SG; Marvaso G; Comi S; Pepa M; Romanò C; Zerini D; Augugliaro M; Russo S; Vischioni B; Valvo F; Giandini T; Avuzzi B; Valdagni R; Ciardo D; De Cobelli O; Jereczek-Fossa BA; Cattani F; Orecchia R
    Phys Med; 2020 Aug; 76():327-336. PubMed ID: 32750548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico comparison of the dosimetric impacts of a greater omentum spacer for abdominal and pelvic tumors in carbon-ion, proton and photon radiotherapy.
    Yamada M; Sato H; Ieko Y; Miyasaka Y; Kanai T; Yano N; Ono T; Akamatsu H; Harada M; Ichikawa M; Teranishi Y; Kikuchi Y; Nemoto K
    Radiat Oncol; 2019 Nov; 14(1):207. PubMed ID: 31752932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.